TITLE
Combined targeting of JAK2 and Bcl-xL/Bcl-2 as a novel curative treatment for malignancies expressing mutant JAK2 and overcoming acquired resistance to single agent JAK2 inhibitors

ORGANISM
Mus musculus

SUMMARY
This SuperSeries is composed of the SubSeries listed below.

DESIGN
Refer to individual Series

PLATFORM
GPL81 [MG_U74Av2] Affymetrix Murine Genome U74A Version 2 Array GPL1261 [Mouse430_2] Affymetrix Mouse Genome 430 2.0 Array

CITATIONS
24268771

